Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Aptamer Group (APTA) by Steve Moore in ShareProphets
- Sell Windar Photonics (WPHO) by Steve Moore in ShareProphets
- Avoid URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Avoid PZ Cussons (PZC) by Steve Moore in ShareProphets
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Sell Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Sell The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Naked Wines (WINE) by Steve Moore in ShareProphets
- Sell Mirriad Advertising (MIRI) by Steve Moore in ShareProphets
- Hold M&G (MNG) by Cliff D'Arcy in The Motley Fool
- Buy Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
- Outperform OSB Group (OSB) by RBC Capital
- Buy Diageo (DGE) by Harvey Jones in The Motley Fool
- Watch Nexteq (NXQ) by Steve Moore in ShareProphets
- Overweight Jet2 (JET2) by Barclays
- Outperform IntegraFin Holding (IHP) by RBC Capital
Faron Pharmaceuticals Oy (DI) (FARN) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Faron Pharmaceuticals Oy (DI) (FARN)
| Latest Bid : 165.00p | Latest Ask : 175.00p |
| High Today : 175.00p | Low Today : 170.00p |
| This Years High : 262.50p | This Years Low : 150.00p |
| Volume : 461 | MKT Cap : £176.8M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Faron Pharmaceuticals Oy (DI) (FARN) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.Faron Pharmaceuticals Oy (DI) (FARN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |
Faron Pharmaceuticals Oy (DI) (FARN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 165.00p | Latest Ask : 175.00p |
| High Today : 175.00p | Low Today : 170.00p |
| This Years High : 262.50p | This Years Low : 150.00p |
| Volume : 461 | MKT Cap : £176.8M |
Faron Pharmaceuticals Oy (DI) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Faron Pharmaceuticals Oy (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |